https://www.selleckchem.com/pr....oducts/ro-20-1724.ht
9%). An increasing trend in the frequency of comorbid diseases (presence of at least one comorbidity 64.7% in all patients vs 75.0% in hospitalized patients) and IL-1 inhibitor usage (17.6% in all patients vs 50.0% in hospitalized patients) was observed in hospitalized patients.Rates of comorbid diseases and IL-1 inhibitor use for FMF were observed to be increased in FMF patients hospitalized for COVID-19.This study aimed to investigate the fetal mortality, including stillborn piglets (S and mummified fetuses (MM), in relation to b